No insider purchase over the last 90 days. The latest, by Goldfarb Max, was filed 29 Nov 2016.
This page follows insider dealings at Medbox, Inc. as filed with SEC (Form 4). Medbox, Inc. has had no insider filing for more than a year; the last one goes back to 29 November 2016.
Our records for Medbox, Inc. go back to 2016, with 273 purchases and no sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
25 of 282 declarations
Medbox, Inc. is a NASDAQ-listed company that specializes in management solutions for the cannabis industry. It offers technologies and services to help businesses comply with regulations and optimize their operations.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2017 | 489,097 USD | -117.3 m USD | n.d. | 10-K |
| Dec 2016 | 261,835 USD | -17.7 m USD | n.d. | 10-K |
| Dec 2015 | 632,737 USD | -50.4 m USD | -0.72 USD | 10-K |
| Dec 2014 | 629,132 USD | -16.5 m USD | -0.55 USD | 10-K |
| Dec 2013 | 2.1 m USD | -3.8 m USD | -0.13 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.